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Despite initially favorable prognosis in patients with 
non-Q-wave acute myocardlal infarction (AMI), 
long-term mortality In thls subset of patients appears 
to be similar to or even greater than that In patients 
wlth Q-wave AMI. The relatively poor late prognosis 
is primarily due to a hlgh lncldence of unstable angi- 
na and recurrent AMI. Between January 1982 and 
January 1987, 114 patients with suitable coronary 
narrowing underwent percutaneous translumlnal cor- 
onary angkplasty (PTCA) for angina pectoris (pre- 
sent elther at rest or during mlld exertion, and de- 
spite optimal pharmacologic therapy), a median of 
31 (range 2 to 382) days after a non-Q-wave AMI. 
Success was achieved In dllatlng the obstmcted ar- 
tery in 98 patients (113 of the 129 dilated arteries). 
Emergency bypass surgery was performed in 7 pa- 
tients. Mean clinical follow-up of 20 (range 3 to 59) 
months was obtained In all patients and revealed no 
deaths. Of the 98 patients wlth successful PTCAs, 8 
(8%) developed a nonfatal recurrent AMl and 82 
(83%) were asymptomatk. However, recurrent an- 
gina affected 31 patients (32%) and was treated 
by repeat PTCA (n = 18), coronary bypass surgery 
(n = 5) or pharmacokgk therapy (n = 8). At fol- 
low-up, 74% of the patients (73 of 98) were 
asymptomatk after a successful PTCA and, if nec- 
essary, a repeat PTCA, without incidence of recur- 
rent AMI, coronary bypass surgery or death. The 
hlgh Initial success rate, low Incidence of subse- 
quent death and late recurrent AMI and sustained 
symptomatic beneflt suggest that PTCA Is an effec- 
tive inltlal treatment strategy In these selected pa- 
tients. 
(Am J Cardlol 1988;81:240-243) 
T he clinical course of patients with non-Q-wave 
acute myocardial infarction (AMI) has been a subject 
of interest. Natural history studies have suggested that, 
compared with Q-wave AMI, non-Q-wave AM1 is as- 
sociated with less necrosis, better left ventricular func- 
tion and lower in-hospital mortality. Despite this more 
favorable initial prognosis, long-term survival for pa- 
tients with non-Q-wave AM1 appears to be similar to 
or even less than that in patients with Q-wave AMI.l-13 
The relatively high mortality rate of patients with non- 
Q-wave AM1 seems to be related to unstable angina or 
subsequent recurrent AM1 in the same area’-‘0 and 
may be preventable if recurrent AM1 can be averted 
with revascularization. 
The present study describes the short- and long- 
term results of consecutive patients treated with per- 
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cutaneous transluminal coronary angioplasty (PTCA) 
for severe angina after a non-Q-wave AMI. 
Methods 
Patients: The study population consisted of 114 pa- 
tients with a non-Q-wave AM1 who underwent PTCA 
between January 1982 and January 1987. All had 
symptoms of angina, either at rest or during mild exer- 
tion, despite optimal pharmacologic therapy. They 
represented 8% of our total PTCA population during 
the study period. Non-Q-wave AM1 was defined in 
this study as prolonged chest pain compatible with 
AMI, associated with electrocardiographic ST-seg- 
ment and T-wave abnormalities without progression 
to pathologic Q waves, but with abnormal elevation of 
the creatinine kinase level (at least twice of the normal 
value) before any intervention. Postinfarction angina 
was considered unstable if it occurred at rest lasting 
for at least 15 minutes and was associated with electro- 
cardiographic manifestations of myocardial ischemia 
without evidence of further myocardial necrosis. 
Patients were selected for PTCA if the ischemia- 
related lesion was suitable for dilatation. The selection 
was based only on symptoms and coronary anatomy, 
and was not influenced by left ventricular function. 
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TABLE I Clinical and Anglographic Data 
I+3 (n) 114 
Male/female 88126 
Age (median, yr) 57 (range 31-74) 
Previous CABGIPTCA 219 
Anterior/inferior non-Q-AM1 73141 
Peak CK enzyme level (median, U/liter) 357 (range 206-972) 
Stable/unstable angina pectoris 61153 
Therapy before procedure: 
Triple therapy (NTG, iv)’ 97 (35) 
Double therapy 17 
Median time from AMI to PTCA (days) 31 (range 2-362) 
Single/double/triple vessel disease 75133/6 
Total occlusion 22 
Single-vessel dilatation 100 
Multivessel dilatation 14 
Initial global ejection fraction (%) 58 f 8 (range 32-71) 
AMI = acute myocardial infarction: CABG = coronary artery bypass graft; 
CK = creatinine phosphckinase (normal <lOO U/liter); PTCA = percutaneous 
transluminal coronary angioplasty. 
l Optimal pharmacologic therapy conslsted of fi blocker, calcium antago- 
nist and nitrates, including 35 patients who needed intravenous nitroglycerin 
(NTG, iv). 
PTCA was considered successful when a reduction of 
the severity of the obstruction to <50% luminal diame- 
ter narrowing was achieved with abolition of acute 
ischemic symptoms and without progression to AMI, 
emergency surgery or death. PTCA was performed a 
median of 31 (range 2 to 362) days after non-Q-wave 
AMI; 53% of the procedures were performed within 
30 days of AMI. Clinical and angiographic data are 
summarized in Table I. After the procedurei patients 
were monitored for 24 hours in the medium care unit. 
They were treated with nifedipine 60 mg daily and 
acetylsalicylic acid 500 mg daily over a period of 6 
months. 
All patients were followed at the outpatient clinic. 
Survival status, recurrent AMI, angina pectoris, cardi- 
TABLE II Anglographlc Results 
PTCA Artery No. Primary Success 
Left anterior descending 78 70 (90%) 
Right 31 27 (87%) 
Left circumflex 20 16 (80%) 
Total 129 113 (68%) 
ac failure, bypass surgery and PTCA were recorded. 
The majority underwent symptom-limited exercise on 
the bicycle ergometer with stepwise increments of 20 
watts every minute. The orthogonal leads XYZ of the 
Frank lead system were recorded. An ischemic re- 
sponse was defined as at least a 0.1 mV ST-segment 
depression, occurring 0.08 seconds after the J point. 
The maximum workload achieved was expressed as a 
percentage of the normal workload predicted for age, 
sex and height. 
Results 
From the 114 patients who underwent PTCA for 
angina after a non-Q-wave AMI, 129 lesions were di- 
lated. Single-vessel dilatation was performed in 100 
patients, including 16 multilesion dilatations in the 
same artery. Double artery dilatation was performed 
in 13 patients and triple artery dilatation in 1 (Table II). 
Success was achieved in dilating the obstructed artery 
in 98 patients (113 lesions). 
Figure 1 shows the clinical outcome of all patients. 
In 16 patients, the attempted PTCA was unsuccessful: 
in 9 because the artery was occluded, in 5 because the 
stenosis could not be crossed with either the guidewire 
or balloon catheter and in 2 because of abrupt closure 
or major dissection, Peri-interventional AMI, defined 
by either cardiac enzyme elevation or new Q waves, 
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FIGURE 1. Short- and long-term (mean, 20 
months) cllnlcal follow-up In 114 patlents undergo- CABS RXUD RE-PTCC 
lng coronary angloplasty (PTCA) for severe anglna 
(AP) after a non-Q-wave myocardlal InfarctIon 
(Ml). CABG = coronary artery bypass grafting; Rx 
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TABLE III Mean Cllnlcal Follow-Up of 20 (Range 3 to 59) Months TABLE IV Time Delay from Non-O-Wave AM to PTCA 
Initial Success Failure 
(it = 98) (n = 16) 
Patients Treated 
<30 days 
Patients Treated 
>30 days 
Death 0 
Emergency CABG 0 
AMI related to PTCA 0 
Late recurrent AMI 6 
Repeat PTCA ia 
Repeat PTCA + CABG 6 
Late CABG 5 
Pharmacologic therapy a 
Event-free 62 
Abbreviations as in Table I. 
was documented in 5 patients, of whom 3 underwent 
emergency bypass Surgery. 
Of the 98 successfully treated patients, 62 were 
asymptomatic and 5 developed a nonfatal recurrent 
AM1 (1 of them underwent an urgent PTCA). Thirty- 
one patients develoIjed recurrent angina and of these, 
5 underwent an elective bypass surge@ 168 (range 7 to 
534) days after the initial procedure, 8 were controlled 
by pharmacologic therapy, and 18 underwent a repeat 
PTCA 120 [range 1 to 300) days after the initial pro&- 
dure. Success was achieved in redilating the artery in 
16 patients. 
Results of electrocardiographic exercise testing 
were available in 71% (70 of 981 of the patients, 8 
(range 1 to 49) months after initially successful PTCA 
(Figure 2). The mean maximum workload achieved, 
predicted for age, sex and height, was 98% (range 54 to 
131%). 
Clinical follow-up was obtained in all patients, at a 
mean interval of 20 (range 3 to 59) months, and is 
% 
100 
I 89% 
w 80% AP ST C 
MAXIMAL WORKLOAD 
FIGURE 2. Results of electrocardlograohlc exirclse testlpg (n = 
70), 8 (iange 1 to 49) months after lnltlally succ+eful PTCA. A 
maximum workload of >80’% and >lOCi% predlcted for &e, sex 
and height was achlived In 89% and 52% of‘the patlents; respec- 
tlvely. The majority of the patlents (92%) were symptom-free dur- 
Ing the test; an lschemlc ST-segment depresslon was documented 
In 27%. 
Number of patients 
Anterior AMI 
Unstable angina 
Initial success rate 
Emergency CABG 
AMI related to PTCA 
Late recurrent AMI 
Repeat PTCAllate CABG 
60 
67% 
72% 
85% 
7% 
5% 
5% 
23% 
54 
60% 
18% 
85% 
5% 
4% 
5% 
22% 
Abbreviations as in Table I. 
summarized in Table III. If coronary artery bypass 
surgery, recurrent AMI, death or recurrent angina re- 
quiring pharmacologic therapy were to be considered 
events, 74% of the patients wodld be considered 
event-free at 20 months after successful PTCA, where- 
as if any cardiac recurrence, including repeat PTCA, 
were to be considered events, only 63% of patients 
would be event-free at 20 months (Figure 3). 
Discussion 
The reported ificidence of non-Q-wave AMI varies 
between 20 and 36% of all AMIs.~,~~~J~ Although non- 
Q-wave AM1 and Q-wave AM1 (as classified by elec- 
trocardiographic results] cannot always be anatomi- 
cally differentiated ,4J4 it seems likely that they differ 
clinically, physiologically and prognostically, as dis- 
cussed by Spodick.15 Despite the initially limited area 
of myocarditil necrosis and favorable short-term p~og- 
nosis for patients with non;Q-wave AMI, several stud- 
ies show substantial late morbidity and mortality rates 
in these patientsI-l3 Despite marked improvement in 
0% 
Death 
Re-PTCA 
Late CABG 
24% 
8% 11 
e!J r15 
Re-MI 
J 
I$ Med Re-PTCA ASympt. 
late CABG 
FIGURE 3. lf coronary artery bypass surgery (CABG), recurrent 
myocardlal lnfarctlbn (re-MI), death or recurrent anglna requiring 
pharmacologic therapy (Rx Med) were to be considered events, 
74% of the patlents would be consldered ivent-free (Asympt.) at 
20 monihs after lnltlally successful angloplasty, whereas If any 
cardiac recurrence, kicludlng repeat coronary angloplasty (Re- 
PTCA) were to be considered an event, only 83% of patients would 
be event-free. 
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pharmacologic therapy, the reported incidence of re- 
current AMIs remains high at 6 to 86% and is associ- 
ated with a poor prognosis. 1,4-6.10,16,17 Ma+1 et a15 rem 
ported a high mortality, both early and late, for 
patients with subsequent extension following a non- 
Q-wave AMI. In-hospital mortality rate in this subset 
of patients was 43%, while in those with Q-wave AM1 
was 15%. The l-year cumulative survival rates for pa- 
tients with Q- versus non-Q-wave AM1 without exten- 
sion were similar: 82% and 84%. For those with exten- 
sion, however, l-year survival rates were 66% and 
3570, respectively. This finding was supported by oth- 
eps.1,3,10,18,19 
Several investigators uggest hat coronary bypass 
surgery or PTCA is feasible and safe for patients with 
angina after non-Q-wave AMI.20-23 Our present re- 
sults indicate not only that PTCA can be performed 
safely and effectively in this subset of patients, but also 
that the incidences of late recurrent AM1 (6%) and 
cardiac death (070) are lower than expected. However, 
recurrent angina occurred in 32% of our patients after 
successful PTCA, a percentage similar to that reported 
for stable angina. 24 All patients were satisfactorily 
treated by repeat PTCA, coronary bypass surgery or 
pharmacologic therapy. These findings are compara- 
ble with the general results of the total PTCA popula- 
tion during the same period, perhaps because PTCA 
was performed in half of the patients >l month after 
non-Q-wave AMI, thus hindering any significant dis- 
tinction between them and an average PTCA popula- 
tion. However, the time delay from non-Q-wave AM1 
to PTCA did not affect the outcome, despite the fact 
that unstable angina was more frequent among the 
patients treated within 30 days than those treated >30 
days, as shown in Table IV. 
Among the 22 patients with a totally occluded ar- 
tery at the time of PTCA, attempted recanalization was 
successful in only 13 (success rate of 59%), and of 
these, repeat PTCA or coronary bypass surgery or both 
was necessary in 6. Of the 9 unsuccessful cases, 3 un- 
derwent emergency bypass surgery, 5 had residual an- 
gina controlled by pharmacologic therapy and 1 was 
asymptomatic. When these patients with a totally oc- 
cluded artery were excluded, the primary success rate 
became 92%. These findings suggest hat when the 
artery is occluded, the benefits of PTCA after a non-Q- 
wave AM1 are limited, even when recanalization is 
initially successful. 
Limitations of this study include the fact that it was 
uncontrolled and involved only patients with non-Q- 
wave AM1 with recurrent angina1 symptoms and anat- 
omy suitable for PTCA. In fact, most patients had a 
single-vessel disease with relatively small to moderate 
enzymatic infarct size and might be expected to have a 
favorable outcome. However, these patients consti- 
tuted a high-risk subgroup because of the presence of 
ongoing angina, which implied that the cardiac event 
was not yet complete and suggested that more aggres- 
sive invasive management could have improved clini- 
cal status and the condition of the myocardium. 
The high initial success rate and the low incidence 
of subsequent death and late recurrent AMI, as well as 
the sustained beneficial effect, suggest that PTCA is an 
effective initial treatment strategy in patients with an- 
gina after a non-Q-wave AMI. 
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